+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biotechnological Strategies for the Treatment of Gluten Intolerance

  • Book

  • May 2021
  • Elsevier Science and Technology
  • ID: 5230546

Biotechnological Strategies for the Treatment of Gluten Intolerance provides a comprehensive overview of a wide range of biotechnological approaches that will further research and upon implementation improve the quality of life of this population. Gluten intolerance is a heterogeneous condition with varying levels of sensitivity that have typically been treated with a gluten free diet, but this book provides new and exciting biotechnological approaches that affect diet as well as non-dietary approaches. The reference describes the varying levels of sensitivity and explores symptoms beyond the intestines for a complete overview of the spectrum of sensitivity. The impact of diversity of wheat species, gluten quality and the nutritional values of gluten free products are extensively discussed. This reference is perfect for researchers and clinicians that want to further treatment options for those suffering from gluten sensitivity.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. Gluten intolerance: The triggering agents 2. Beyond the intestine 3. New dietary approaches 4. Non-dietary approaches

Authors

Mauro Rossi Research Director, CNR-ISA, Avellino, Italy. Mauro Rossi is Research Director at the Italian National Research Council (CNR)-Institute of Food Sciences (ISA) and Head of the Immunobiology Unit. He has 30 years of work experience in the field of the Biochemistry and Immunology of the small intestine. In the 1990s, he worked in the laboratories of Professor Auricchio (University "Federico II� of Naples, Italy), Noren (Panum Institute, Copenhagen, Denmark), Semenza (ETH, Zurich, Switzerland) on the biosynthesis of intestinal disaccharidases and lactose intolerance (adult-type hypolactasia), and Professor Londei (Kennedy Institute of Rheumatology, London, United Kingdom) on the cellular and molecular aspects of antigen-specific T-cell activation. His research focuses on the immunology of the small intestine, mainly on the mechanisms of tolerance to food antigens and on the development of microbiological and enzymatic strategies to downregulate the intestinal hypersensitivity to wheat gluten. He is also involved in basic and oriented applied research on probiotics.